What is driving PATH stock today?

PATH stock moved lower intraday on 15 Jan 2026 after CEO insider sales and increased trading volume. Investors are weighing near-term sentiment against UiPath’s AI automation revenue growth and upcoming earnings on 11 Mar 2026.

What price targets exist for PATH stock?

Analyst targets range from **USD 13.00** to **USD 19.00**, with MarketBeat consensus near **USD 16.00**. Meyka AI’s 12-month model forecast is **USD 16.65**, implying about **10.30%** upside from **USD 15.095**.

How does Meyka AI rate PATH stock?

Meyka AI rates PATH with a score out of 100: **75.20 (B+) — BUY**. The grade factors S&P 500 and sector comparisons, financial growth, metrics, forecasts and analyst consensus. This is informational and not investment advice.

What are the main risks for PATH stock investors?

Key risks for PATH stock include valuation sensitivity given PE **36.58**, potential slowdown in enterprise IT spending, continued insider selling pressure, and execution risk as UiPath scales AI products globally.

US Stocks

PATH (UiPath Inc., NYSE) at $15.10 intraday 15 Jan 2026: AI automation growth vs. insider sales

ByHuzaifa Zahoor January 15, 2026January 15, 2026

UiPath Inc. (PATH) trades USD 15.095 intraday on the NYSE on 15 Jan 2026 after a -5.48% session move. PATH stock is reacting to recent insider sales and renewed investor focus on AI-led automation demand. We review key financials, technical signals, analyst price targets and our model forecast to frame a clear short-term and medium-term outlook for PATH stock on this trading day.